Indications and uses
For the temporary relief of: Minor joint pain and stiffness
For the temporary relief of: Minor joint pain and stiffness
Direction for use: Adults: Apply in the morning and evening to the effected areas, rubbing in gently. If appropriate, also apply an ointment dressing. Children under 18 years of age see a doctor.
Active ingredients: Each 50g of ointment contains: Silicea 6X 0.5g; Symphytum officinale 8X 0.375g; Arnica montana, radix 2X 0.15g; Rhus toxicodendron 2X 0.135g; Sulphur 6X 0.135g; Sanguinaria canadensis 2X 0.113g; Dulcamara 2X 0.038g; Coenzyme A 6X 0.005g; Nadidum 6X 0.005g; Natrum oxalaceticum 6X 0.005g; α- Lipoicum acidum 6X 0.005g; Cartilago suis 2X 0.0005g; Embryo suis 2X 0.0005g; Funiculus umbilicalis suis 2X 0.0005g; Placenta suis 2X 0.0005g.
Minor joint pain and stiffness
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51885-3353-1 | 2019-11-13 | C162847 | 48780-1 | 97449f38-b89a-f6ea-e053-dbdaa90aa703 | 9cd09f43-5049-4aaf-9cae-a017dcb39cf0 |
| 51885-3353-3 | 2019-11-13 | C162847 | 48780-1 | 97449f38-b89a-f6ea-e053-dbdaa90aa703 | 9cd09f43-5049-4aaf-9cae-a017dcb39cf0 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51885-3353-1 | Zeel | 1 in 1 CARTON | OINTMENT | 1 | 1 | |
| 51885-3353-1 | Zeel | 50 g in 1 TUBE | OINTMENT | 50 | 1 | |
| 51885-3353-3 | Zeel | 1 in 1 CARTON | OINTMENT | 1 | 1 | |
| 51885-3353-3 | Zeel | 50 g in 1 TUBE | OINTMENT | 50 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51885-3353 | ZEEL (SILICON DIOXIDE AND COMFREY ROOT AND ARNICA MONTANA ROOT AND TOXICODENDRON PUBESCENS LEAF AND SULFUR AND SANGUINARIA CANADENSIS ROOT AND SOLANUM DULCAMARA STEM AND COENZYME A AND NADIDE AND SODIUM DIETHYL OXALACETATE AND .ALPHA.-LIPOIC ACID AND SUS SCROFA CARTILAGE AND SUS SCROFA EMBRYO AND SUS SCROFA UMBILICAL CORD AND SUS SCROFA PLACENTA AND ) OINTMENT [BIOLOGISCHE HEILMITTEL HEEL] | 1 | Legacy NDC, 4 package rows | 20120228_9cd09f43-5049-4aaf-9cae-a017dcb39cf0.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .ALPHA.-LIPOIC ACID | ACTIVE INGREDIENT | 73Y7P0K73Y | 1 | |
| ARNICA MONTANA ROOT | ACTIVE INGREDIENT | MUE8Y11327 | 1 | |
| COENZYME A | ACTIVE INGREDIENT | SAA04E81UX | 1 | |
| COMFREY ROOT | ACTIVE INGREDIENT | M9VVZ08EKQ | 1 | |
| NADIDE | ACTIVE INGREDIENT | 0U46U6E8UK | 1 | |
| SANGUINARIA CANADENSIS ROOT | ACTIVE INGREDIENT | N9288CD508 | 1 | |
| SILICON DIOXIDE | ACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| SODIUM DIETHYL OXALACETATE | ACTIVE INGREDIENT | 6CA025Y4FG | 1 | |
| SOLANUM DULCAMARA STEM | ACTIVE INGREDIENT | IR986LE7DF | 1 | |
| SULFUR | ACTIVE INGREDIENT | 70FD1KFU70 | 1 | |
| SUS SCROFA CARTILAGE | ACTIVE INGREDIENT | 73ECW5WG2F | 1 | |
| SUS SCROFA EMBRYO | ACTIVE INGREDIENT | 9928MC12VO | 1 | |
| SUS SCROFA PLACENTA | ACTIVE INGREDIENT | C8CV8867O8 | 1 | |
| SUS SCROFA UMBILICAL CORD | ACTIVE INGREDIENT | 118OYG6W3H | 1 | |
| TOXICODENDRON PUBESCENS LEAF | ACTIVE INGREDIENT | 6IO182RP7A | 1 | |
| .ALPHA.-LIPOIC ACID | ACTIVE MOIETY | 73Y7P0K73Y | 1 | |
| ARNICA MONTANA ROOT | ACTIVE MOIETY | MUE8Y11327 | 1 | |
| COENZYME A | ACTIVE MOIETY | SAA04E81UX | 1 | |
| COMFREY ROOT | ACTIVE MOIETY | M9VVZ08EKQ | 1 | |
| NADIDE | ACTIVE MOIETY | 0U46U6E8UK | 1 | |
| SANGUINARIA CANADENSIS ROOT | ACTIVE MOIETY | N9288CD508 | 1 | |
| SILICON DIOXIDE | ACTIVE MOIETY | ETJ7Z6XBU4 | 1 | |
| SODIUM | ACTIVE MOIETY | 9NEZ333N27 | 1 | |
| SOLANUM DULCAMARA STEM | ACTIVE MOIETY | IR986LE7DF | 1 | |
| SULFUR | ACTIVE MOIETY | 70FD1KFU70 | 1 | |
| SUS SCROFA CARTILAGE | ACTIVE MOIETY | 73ECW5WG2F | 1 | |
| SUS SCROFA EMBRYO | ACTIVE MOIETY | 9928MC12VO | 1 | |
| SUS SCROFA PLACENTA | ACTIVE MOIETY | C8CV8867O8 | 1 | |
| SUS SCROFA UMBILICAL CORD | ACTIVE MOIETY | 118OYG6W3H | 1 | |
| TOXICODENDRON PUBESCENS LEAF | ACTIVE MOIETY | 6IO182RP7A | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| CETOSTEARYL ALCOHOL | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| PARAFFIN | INACTIVE INGREDIENT | I9O0E3H2ZE | 1 | |
| PETROLATUM | INACTIVE INGREDIENT | 4T6H12BN9U | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 51885-3353 | 51885-3353-1, 51885-3353-3 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | LOTION / TOPICAL | 25 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | OINTMENT / TOPICAL | 1.2 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | TABLET, EXTENDED RELEASE / ORAL | 800 mg | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | AEROSOL, FOAM / TOPICAL | 14235 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | CAPSULE, EXTENDED RELEASE / ORAL | 9.43 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | TABLET / ORAL | 0.7 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | TABLET, EXTENDED RELEASE / ORAL | 0.18 mg | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | CAPSULE, EXTENDED RELEASE / ORAL | 100 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | OINTMENT / RECTAL | 38 mg | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | TABLET, EXTENDED RELEASE / ORAL | 321 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | SPRAY / TOPICAL | 1 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT, AUGMENTED / TOPICAL | 81.94 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CAPSULE, EXTENDED RELEASE / ORAL | 0.07 mg | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | TABLET, COATED / ORAL | 0.07 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CREAM, AUGMENTED / TOPICAL | 26 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | OINTMENT / TOPICAL | 2860 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / AURICULAR (OTIC) | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | CREAM / TOPICAL | 1428 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | TABLET, DELAYED RELEASE / ORAL | 0.2 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | CREAM / TOPICAL | 300 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | EMULSION / TOPICAL | 7.8 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| fe3f3fc6-bf04-416d-b1a9-f2a39935608a | 9cd09f43-5049-4aaf-9cae-a017dcb39cf0 | 2012-02-28 | Warnings | fe3f3fc6-bf04-416d-b1a9-f2a39935608a 9cd09f43-5049-4aaf-9cae-a017dcb39cf0 |
Adverse event summaries are temporarily unavailable. Other product information remains available.